Literature DB >> 3336887

Failure of heparin to prevent progression in progressing ischemic infarction.

E C Haley1, N F Kassell, J C Torner.   

Abstract

Anticoagulation with heparin is frequently recommended for patients with progressing ischemic cerebral infarction, yet little data is available detailing the acute results of treatment with this agent. We report the results of continuous intravenous heparin treatment in 36 consecutive patients admitted with progressing ischemic infarction, all of whom had computed tomography scans to exclude the diagnosis of hemorrhage prior to treatment. Overall, 18 of 36 (50%) had continued neurologic worsening despite treatment. The incidence of further worsening was greater in carotid territory infarctions (14 of 19, 74%) than in either vertebrobasilar (2 of 8, 25%) or lacunar (2 of 9, 22%) infarctions (p less than 0.05, Fisher's exact test). These observations suggest that additional controlled studies of the efficacy of heparin in progressing ischemic infarction are warranted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336887     DOI: 10.1161/01.str.19.1.10

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

Review 1.  Identification and management of difficult stroke and TIA syndromes.

Authors:  M M Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

Review 2.  Clinical, radiological, and functional evaluation following acute stroke.

Authors:  D G Grosset
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

Review 3.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 4.  Critical care of acute ischemic stroke.

Authors:  W Hacke; R Stingele; T Steiner; V Schuchardt; S Schwab
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

5.  Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage.

Authors:  T F Choudhri; B L Hoh; C J Prestigiacomo; J Huang; L J Kim; A M Schmidt; W Kisiel; E S Connolly; D J Pinsky
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

Review 6.  What have drugs to offer the patient with acute stroke?

Authors:  D G Grosset
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

Review 7.  Antithrombotic therapy for patients with stroke symptoms. Guidelines for family physicians.

Authors:  J Brown; M Bernstein
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

Review 8.  Manipulation of coagulation factors in acute stroke.

Authors:  J F Meschia; J Biller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

9.  Anticoagulant therapy for ischemic stroke: A review of literature.

Authors:  Mohammad Mehdi Shahpouri; Seyed Mousavi; Faribourz Khorvash; Seyed Morteza Mousavi; Tahereh Hoseini
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.